PsiloTec
Zylorion is dedicated to transforming brain health through innovative neuroplasticity treatments. Their mission is to develop breakthrough therapies for neurodegenerative diseases by enhancing neuroplasticity using novel drugs. The company focuses on neuroplasticity, disease modification, and scalable solutions, aiming to make a significant impact on hard-to-treat brain diseases with safe and effective drugs. Their lead compound, ZYL-314, is a patented drug designed to enhance BDNF / TrkB activation, supporting neuroplasticity and potentially treating conditions like Alzheimer’s Disease, MCI, PTSD, and other neurodegenerative and neuropsychiatric disorders.
Industries
Nr. of Employees
medium (51-250)
Products
Lead oral neuroplasticity clinical candidate (co‑crystal‑stabilized)
A lead small‑molecule clinical candidate formulated as a stable co‑crystal salt to enable rapid oral absorption of an oxygen‑sensitive active compound that enhances BDNF/TrkB activation; demonstrated preclinical increases in BDNF, TrkB phosphorylation, neurogenesis, and synaptogenesis.
Lead oral neuroplasticity clinical candidate (co‑crystal‑stabilized)
A lead small‑molecule clinical candidate formulated as a stable co‑crystal salt to enable rapid oral absorption of an oxygen‑sensitive active compound that enhances BDNF/TrkB activation; demonstrated preclinical increases in BDNF, TrkB phosphorylation, neurogenesis, and synaptogenesis.
Services
Partnerships and collaborations for co-development, licensing, and clinical translation of CNS therapeutic candidates; inquiries handled via contact form.
Partnerships and collaborations for co-development, licensing, and clinical translation of CNS therapeutic candidates; inquiries handled via contact form.
Expertise Areas
- Neuroplasticity drug discovery
- Preclinical pharmacology for CNS indications
- Oral small‑molecule formulation and CMC
- Biomarker-driven assay development
Key Technologies
- BDNF/TrkB pathway modulation
- Co-crystal salt formulation for compound stabilization
- Oral bioavailability enhancement
- In vivo neuroplasticity models
News & Updates
Join Our Mission
Learn more about partnership opportunities with Zylorion.
Join Our Mission
Learn more about partnership opportunities with Zylorion.